ArticleJCO global oncology2023

Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?

Ankit ManglaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.